Literature DB >> 15334061

FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.

Maria Rita Rippo1, Simona Moretti, Silvia Vescovi, Marco Tomasetti, Sara Orecchia, Giuseppe Amici, Alfonso Catalano, Antonio Procopio.   

Abstract

Tumors have developed several forms of resistance to receptor-induced cell death. Here, we show that malignant mesothelial (MM) cell lines as well as primary MM cells and normal mesothelial (NM) cells express Fas and TNF-related apoptosis-inducing ligand (TRAIL) receptors DR4 and DR5. We found that, although Fas expression levels are comparable, only MM cells are resistant to cell death. Furthermore, MM cells show resistance to TRAIL-induced apoptosis. Caspase-8 (FLICE) is not activated by death receptors triggering in malignant cells whereas it is well activated by nonreceptor stimuli, such as UV radiation. We found that FLIP (FLICE-Inhibitory Protein) is constitutively expressed in all MM cell lines and is more expressed in primary MM cells than in NM cells. Knockdown of FLIP expression in MM cell lines, by a FLIPsiRNA, re-established the normal response to apoptosis induced by Fas or DR4/DR5, which was blocked by pretreatment with the caspase-8 inhibitor z-IETD-fmk. These results indicate that MM cells develop an intrinsic resistance to apoptosis induced by death receptors upregulating the expression of the antiapoptotic protein c-FLIP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334061     DOI: 10.1038/sj.onc.1208051

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  B lymphocytes are resistant to death receptor 5-induced apoptosis.

Authors:  Roslyn N Crowder; Hong Zhao; W Winn Chatham; Tong Zhou; Robert H Carter
Journal:  Clin Immunol       Date:  2011-01-28       Impact factor: 3.969

2.  5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation.

Authors:  Alfonso Catalano; Sabrina Rodilossi; Paola Caprari; Vincenzo Coppola; Antonio Procopio
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

3.  MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function.

Authors:  Marco Tomasetti; Linda Nocchi; Sara Staffolani; Nicola Manzella; Monica Amati; Jacob Goodwin; Katarina Kluckova; Maria Nguyen; Elisabetta Strafella; Martina Bajzikova; Martin Peterka; Sandra Lettlova; Jaroslav Truksa; Wan Lee; Lan-Feng Dong; Lory Santarelli; Jiri Neuzil
Journal:  Antioxid Redox Signal       Date:  2014-04-23       Impact factor: 8.401

Review 4.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

5.  Phosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza A matrix 1 protein function.

Authors:  Umesh Chandra Halder; Rahul Bhowmick; Tapasi Roy Mukherjee; Mukti Kant Nayak; Mamta Chawla-Sarkar
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

6.  Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

Authors:  Jun Yang; P K Epling-Burnette; Jeffrey S Painter; Jianxiang Zou; Fanqi Bai; Sheng Wei; Thomas P Loughran
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

7.  Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.

Authors:  Imtiyaz Murtaza; Mohammad Saleem; Vaqar Mustafa Adhami; Bilal Bin Hafeez; Hasan Mukhtar
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 8.  Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

Authors:  Ahmad R Safa; Travis W Day; Ching-Huang Wu
Journal:  Curr Cancer Drug Targets       Date:  2008-02       Impact factor: 3.428

9.  Overexpression of cFLIP in head and neck squamous cell carcinoma and its clinicopathologic correlations.

Authors:  Xiuguo Li; Xinliang Pan; Hui Zhang; Dapeng Lei; Dayu Liu; Fenglei Xu; Xinyong Luan
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-09       Impact factor: 4.553

10.  Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.

Authors:  Manonmani Ganapathy; Rita Ghosh; Xie Jianping; Xiaoping Zhang; Roble Bedolla; John Schoolfield; I-Tien Yeh; Dean A Troyer; Aria F Olumi; Addanki P Kumar
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.